
Dimension Secures $500M for Biotech and AI Convergence Fund
Dimension, a venture capital firm, has successfully raised a $500 million second fund to invest in the intersection of biotechnology and machine learning, an area they describe as 'still contrary.' The firm, led by managing partners in New York and the Bay Area, aims to capitalize on the growing synergy between biological sciences and AI technologies.
